3D Image Analysis Reveals Differences of CD30 Positive Cells and Network Formation in Reactive and Malignant Human Lymphoid Tissue (classical Hodgkin Lymphoma)
Overview
Affiliations
Aims: The examination of histological sections is still the gold standard in diagnostic pathology. Important histopathological diagnostic criteria are nuclear shapes and chromatin distribution as well as nucleus-cytoplasm relation and immunohistochemical properties of surface and intracellular proteins. The aim of this investigation was to evaluate the benefits and drawbacks of three-dimensional imaging of CD30+ cells in classical Hodgkin Lymphoma (cHL) in comparison to CD30+ lymphoid cells in reactive lymphoid tissues.
Materials And Results: Using immunoflourescence confocal microscopy and computer-based analysis, we compared CD30+ neoplastic cells in Nodular Sclerosis cHL (NScCHL), Mixed Cellularity cHL (MCcHL), with reactive CD30+ cells in Adenoids (AD) and Lymphadenitis (LAD). We confirmed that the percentage of CD30+ cell volume can be calculated. The amount in lymphadenitis was approx. 1.5%, in adenoids around 2%, in MCcHL up to 4,5% whereas the values for NScHL rose to more than 8% of the total cell cytoplasm. In addition, CD30+ tumour cells (HRS-cells) in cHL had larger volumes, and more protrusions compared to CD30+ reactive cells. Furthermore, the formation of large cell networks turned out to be a typical characteristic of NScHL.
Conclusion: In contrast to 2D histology, 3D laser scanning offers a visualisation of complete cells, their network interaction and spatial distribution in the tissue. The possibility to differentiate cells in regards to volume, surface, shape, and cluster formation enables a new view on further diagnostic and biological questions. 3D includes an increased amount of information as a basis of bioinformatical calculations.
Hansmann M Pathologie (Heidelb). 2023; 44(Suppl 3):140-143.
PMID: 38010387 DOI: 10.1007/s00292-023-01265-7.
Imaging bridges pathology and radiology.
Martin-Leo H, Frederick K, Wojciech S, Klaus-Robert M, Emmanuel D, Sonja S J Pathol Inform. 2023; 14:100298.
PMID: 36851923 PMC: 9958472. DOI: 10.1016/j.jpi.2023.100298.
Bein J, Flinner N, Haupl B, Mathur A, Schneider O, Abu-Ayyad M J Cell Mol Med. 2022; 26(12):3495-3505.
PMID: 35586951 PMC: 9189347. DOI: 10.1111/jcmm.17389.
Sadeghi Shoreh Deli A, Scharf S, Steiner Y, Bein J, Hansmann M, Hartmann S Mod Pathol. 2022; 35(10):1431-1438.
PMID: 35173297 PMC: 9514992. DOI: 10.1038/s41379-022-01016-8.
Thomos M, Wurzel P, Scharf S, Koch I, Hansmann M PLoS One. 2020; 15(11):e0242177.
PMID: 33170900 PMC: 7654765. DOI: 10.1371/journal.pone.0242177.